The Accreditation Council for CME responded to a letter of inquiry from the U.S. Senate Special Committee on Aging this week, answering questions the committee had about its accreditation process and mechanisms to prevent industry influence. The committee, chaired by Sen. Herb Kohl (D-Wis.), is concerned that pharmaceutical companies use CME as a marketing tool. “Of particular concern are instances where drug companies use CME courses to encourage physicians to use their products for ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the ACCME Responds to Senate Concerns, you'll also gain access to exclusive premium content.

Already registered? here.